GRI Bio, Inc. (GRI) vs HCW Biologics Inc. (HCWB)
GRI Bio, Inc. and HCW Biologics Inc. are both Biotechnology companies. GRI Bio, Inc. and HCW Biologics Inc. are of similar size ($4.6M and $4.2M). HCW Biologics Inc. has negative trailing earnings, so its P/E is not meaningful; GRI Bio, Inc. trades at 0.0×. GRI Bio, Inc. has the higher net margin (0.00% vs −329.4%) and the higher return on invested capital (0.00% vs −36.2%). Across the 14 metrics below, GRI Bio, Inc. leads on 10 and HCW Biologics Inc. on 4.
Valuation
Profitability
| Metric | GRI | HCWB | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 95.91% | 65.16% |
| Operating margin | 0.00% | (114.02%) | 0.00% |
| Net margin | 0.00% | (329.38%) | 0.00% |
| Free cash flow margin | 0.00% | (180.57%) | 0.00% |
| Return on equity | (142.02%) | (600.32%) | (57.72%) |
| Return on assets | (113.27%) | (79.52%) | (49.22%) |
| Return on invested capital | 0.00% | (36.15%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack